» Articles » PMID: 35535900

Evolution of the ErbB Gene Family and Analysis of Regulators of Expression During Development of the Rat Spinal Cord

Overview
Date 2022 May 10
PMID 35535900
Authors
Affiliations
Soon will be listed here.
Abstract

Egfr, a member of the ErbB gene family, plays a critical role in tissue development and homeostasis, wound healing, and disease. However, expression and regulators of Egfr during spinal cord development remain poorly understood. In this study, we investigated ErbB evolution and analyzed co-expression modules, miRNAs, and transcription factors that may regulate Egfr expression in rats. We found that ErbB family members formed via Egfr duplication in the ancient vertebrates but diverged after speciation of gnathostomes. We identified a module that was co-expressed with Egfr, which involved cell proliferation and blood vessel development. We predicted 25 miRNAs and nine transcription factors that may regulate Egfr expression. Dual-luciferase reporter assays showed six out of nine transcription factors significantly affected Egfr promoter reporter activity. Two of these transcription factors (KLF1 and STAT3) inhibited the Egfr promoter reporter, whereas four transcription factors (including FOXA2) activated the Egfr promoter reporter. Real-time PCR and immunofluorescence experiments showed high expression of FOXA2 during the embryonic period and FOXA2 was expressed in the floor plate of the spinal cord, suggesting the importance of FOXA2 during embryonic spinal cord development. Considering the importance of Egfr in embryonic spinal cord development, wound healing, and disease (specifically in cancer), regulatory elements identified in this study may provide candidate targets for nerve regeneration and disease treatment in the future.

Citing Articles

Repurposing EGFR Inhibitors for Oral Cancer Pain and Opioid Tolerance.

Santi M, Zhang M, Liu N, Viet C, Xie T, Jensen D Pharmaceuticals (Basel). 2023; 16(11).

PMID: 38004424 PMC: 10674507. DOI: 10.3390/ph16111558.

References
1.
Guo N, Zhao Y, Zhang W, Li S, Li S, Yu J . MicroRNA-133a downregulated EGFR expression in human non-small cell lung cancer cells via AKT/ERK signaling. Oncol Lett. 2018; 16(5):6045-6050. PMC: 6176458. DOI: 10.3892/ol.2018.9399. View

2.
Li Y, Liu X, Zhang C, Zhou J, Shao Y, Liang C . MicroRNA-34a/EGFR axis plays pivotal roles in lung tumorigenesis. Oncogenesis. 2017; 6(8):e372. PMC: 5608916. DOI: 10.1038/oncsis.2017.50. View

3.
Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey M, Baker M . The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 2020; 18(7):e3000410. PMC: 7360023. DOI: 10.1371/journal.pbio.3000410. View

4.
Agarwal V, Bell G, Nam J, Bartel D . Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015; 4. PMC: 4532895. DOI: 10.7554/eLife.05005. View

5.
Kim B, Yoo H, Choi K, Yoon S . miR-330-5p inhibits proliferation and migration of keratinocytes by targeting Pdia3 expression. FEBS J. 2015; 282(24):4692-702. DOI: 10.1111/febs.13523. View